AlphaYouCMPX: Lerner Neil discloses a purchase
By AlphaYouPublished Form 4
Lerner Neil
Reporting filer
Lerner Neil reported Purchase in Compass Therapeutics, Inc.: 2500 units of Common Stock, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 25, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Lerner Neil | 2026-09-24 | P | Purchase | 2500 | 1.14 | 400,000 | 1 day | Filed terms
|
Common Stock
- Owner
- Lerner Neil
- Date
- 2026-09-24
- Code
- P
- Action
- Purchase
- Quantity
- 2500
- Price
- 1.14
- Following holdings
- 400,000
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-24
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 2500
- transaction Price Per Share: 1.14
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 400000
- id: F1
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Lerner Neil: Chief Accounting Officer.
- F1: 62,500 of the shares represents unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027.
Original sources
Prepared automatically from public filing data. Report a correction.